# Nasopharyngeal Swabs for Orientia tsutsugamushi Detection in Doxycycline Treatment: A Prospective Cohort Study in Hainan, China

**Authors:** Yuanze Chen, Siqi Chen, Jiajia An, Xiaojing Zheng, Qi Wang, Yuyan Wang, Wenjing Fu, Biao Wu, Yongguo Du, Feifei Yin, Liyuan Zhang

PMC · DOI: 10.3390/pathogens15020158 · Pathogens · 2026-02-02

## TL;DR

Nasopharyngeal swabs can detect scrub typhus bacteria shortly after starting doxycycline treatment, offering a noninvasive option for follow-up when blood testing becomes less reliable.

## Contribution

Nasopharyngeal swabs are proposed as a supplementary noninvasive specimen for short-term follow-up of scrub typhus during doxycycline treatment.

## Key findings

- Before treatment, 75% of blood samples and 25% of nasopharyngeal swabs tested positive for O. tsutsugamushi DNA.
- At 24 hours after doxycycline, blood samples were all negative, but 15% of nasopharyngeal swabs remained positive.
- Nasopharyngeal swab positives showed high genetic homology with blood samples, suggesting consistent strain detection.

## Abstract

Scrub typhus, caused by Orientia tsutsugamushi, remains a neglected cause of acute febrile illness. Molecular testing of blood supports early diagnosis, yet once doxycycline is started, blood qPCR positivity can drop rapidly, complicating short-term follow-up and relapse surveillance. We compared detection across multiple clinical specimens and evaluated nasopharyngeal swabs (NPSs) as noninvasive supplementary specimens during treatment initiation. In a prospective single-center cohort from Hainan, China, we enrolled 20 patients with scrub typhus. Blood, NPS, urine, and stool were collected before doxycycline administration 24 h after the first dose and on day 5. qPCR was performed for the analysis of Orientia tsutsugamushi. qPCR-positive specimens were subjected to nested PCR targeting TSA56, and nested PCR-positive amplicons were Sanger sequenced for genotyping. Before treatment, O. tsutsugamushi DNA was detected in 15/20 blood samples (75.00%) and 5/20 NPS samples (25.00%), but 0/20 urine samples (0%) and 0/20 stool samples (0%). At 24 h after treatment, detection in blood was 0/20 (0%) while NPS samples were positive in 3/20 (15.00%). All specimens were negative by day 5 after treatment. Across sequenced NPS positives (n = 3), Karp 2/3 (66.77%) and Gilliam 1/3 (33.33%) predominated. In paired blood–NPS positives, inter-specimen homology was high (percentage nucleotide identity 100% for Karp and 100% for Gilliam). NPS is not sensitive enough for primary diagnosis; however, within the first 24 h after doxycycline it offers a practical, noninvasive supplementary specimen to support short-term follow-up and community-based sampling when venipuncture or transport are constrained. Larger, multi-center studies are warranted to refine sampling windows and diagnostic performance.

## Linked entities

- **Chemicals:** doxorubicin (PubChem CID 31703)
- **Diseases:** scrub typhus (MONDO:0019365)
- **Species:** Orientia tsutsugamushi (taxon 784)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CALCA (calcitonin related polypeptide alpha) [NCBI Gene 796] {aka CALC1, CGRP, CGRP-I, CGRP-alpha, CGRP1, CT}, NPS (neuropeptide S) [NCBI Gene 594857], tsa56 (type-specific antigen TSA56) [NCBI Gene 89459812] {aka UT76HP_01865}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}
- **Diseases:** chills (MESH:D023341), abnormal coagulation (MESH:D001778), infected (MESH:D007239), dizziness (MESH:D004244), abnormal liver and kidney function (MESH:D000014), cardiovascular abnormalities (MESH:D018376), infectious disease (MESH:D003141), lacunar infarction (MESH:D059409), central nervous system abnormalities (MESH:D063647), injury to (MESH:D014947), inflammatory (MESH:D007249), headache (MESH:D006261), fever (MESH:D005334), atrial premature beats (MESH:D018880), Scrub typhus (MESH:D012612), multiple organ failure (MESH:D009102), lesions (MESH:D009059), splenomegaly (MESH:D013163), acute febrile illness (MESH:D000071072), systemic rash (MESH:D005076), lymphadenopathy (MESH:D008206), pleural effusion (MESH:D010996)
- **Chemicals:** Cr (MESH:D002857), PX714883 (-), OT (MESH:C013307), CQ (MESH:C048021), creatinine (MESH:D003404), EDTA (MESH:D004492), saline (MESH:D012965), Doxycycline (MESH:D004318), oxygen (MESH:D010100), acid (MESH:D000143)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Tunga penetrans (chigger, species) [taxon 214035], Orientia tsutsugamushi (species) [taxon 784]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942918/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12942918/full.md

## References

25 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942918/full.md

---
Source: https://tomesphere.com/paper/PMC12942918